Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the efficacy and safety of benralizumab in adults with mild to moderate persistent asthma; the trial has completed and results have bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• FASENRA (BENRALIZUMAB)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2017-02-14